		December 28,		December 29,
		2013		2012
Investment in unconsolidated affiliates		$	205,556	$	191,075
Non-current deferred foreign, state and local income taxes			48,470		37,737
Notes receivable (1)			10,836		9,851
Auction rate securities, net of temporary impairment			2,654		2,816
Distribution rights and exclusivity agreements, net of amortization			3,321		4,030
Security deposits			3,341		3,291
Debt issuance costs, net of amortization			2,011		7,207
Acquisition related indemnification			13,880		14,168
Acquisition related loan receivable (2)			145,000		-
Other long-term assets			26,876		22,759
	Total	$	461,945	$	292,934


(1)	Long-term notes receivable carry interest rates ranging from 2.17% to 12.0% and are due in varying installments through
	December 31, 2020.

(2)	See Note 9 - Business Acquisitions, Divestiture and Other Transaction for additional details of the loan receivable from
	BioHorizons, Inc.

Amortization expense related to other long-term assets for the years ended December 28, 2013, December 29, 2012 and December 31, 2011 was $6.0 million, $4.6 million and $4.0 million.